Idorsia Ltd
SIX:IDIA
Idorsia Ltd
Gross Profit
Idorsia Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Idorsia Ltd
SIX:IDIA
|
Gross Profit
CHf90.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Gross Profit
$67m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Gross Profit
CHf130.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
12%
|
|
Kuros Biosciences AG
SIX:KURN
|
Gross Profit
CHf28.5m
|
CAGR 3-Years
157%
|
CAGR 5-Years
115%
|
CAGR 10-Years
N/A
|
See Also
What is Idorsia Ltd's Gross Profit?
Gross Profit
90.8m
CHF
Based on the financial report for Dec 31, 2022, Idorsia Ltd's Gross Profit amounts to 90.8m CHF.